Shp2 regulates PM2.5-induced airway epithelial barrier dysfunction by modulating ERK1/2 signaling pathway

Toxicol Lett. 2021 Oct 10:350:62-70. doi: 10.1016/j.toxlet.2021.07.002. Epub 2021 Jul 9.

Abstract

The impact of fine particulate matter (PM2.5) on public health has received increasing attention. Through various biochemical mechanisms, PM2.5 alters the normal structure and function of the airway epithelium, causing epithelial barrier dysfunction. Src homology domain 2-containing protein tyrosine phosphatase 2 (Shp2) has been implicated in various respiratory diseases; however, its role in PM2.5-induced epithelial barrier dysfunction remains unclear. Herein, we assessed the regulatory effects of Shp2 on PM2.5-mediated epithelial barrier function and tight junction (TJ) protein expression in both mice and human pulmonary epithelial (16HBE) cells. We observed that Shp2 levels were upregulated and claudin-4 levels were downregulated after PM2.5 stimulation in vivo and in vitro. Mice were exposed to PM2.5 to induce acute lung injury, and disrupted epithelial barrier function, with decreased transepithelial electrical resistance (TER) and increased paracellular flux that was observed in 16HBE cells. In contrast, the selective inhibition or knockdown of Shp2 retained airway epithelial barrier function and reversed claudin-4 downregulation that triggered by PM2.5, and these effects may occur through the ERK1/2 MAPK signaling pathway. These data highlight an important role of Shp2 in PM2.5-induced airway epithelial barrier dysfunction and suggest a possible new course of therapy for PM2.5-induced respiratory diseases.

Keywords: Airway Epithelial barrier; Claudin-4; ERK1/2; PM2.5; Shp2; Tight junctions.

MeSH terms

  • Acute Lung Injury / metabolism*
  • Acute Lung Injury / physiopathology*
  • Animals
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Humans
  • MAP Kinase Signaling System* / drug effects
  • Male
  • Mice
  • Mice, Inbred ICR
  • Models, Animal
  • Particulate Matter / toxicity*
  • Tight Junction Proteins / drug effects
  • Tight Junction Proteins / metabolism*
  • src Homology Domains / drug effects*

Substances

  • Particulate Matter
  • Tight Junction Proteins